Applied UV Inc
NASDAQ:AUVI
Intrinsic Value
Applied UV, Inc. engages in the development and acquisition of technology that address infection prevention in the healthcare, hospitality, commercial and residential markets. [ Read More ]
The intrinsic value of one
AUVI
stock under the Base Case scenario is
24.0184
USD.
Compared to the current market price of 0.5755 USD,
Applied UV Inc
is
Undervalued by 98%.
Applied UV Inc's market capitalization is 719.4k USD.
AUVI stock price is 0.5755 USD.
AUVI stock price (0.5755 USD) is 98% less than its Intrinsic Value (24.0184 USD).
AUVI stock price (0.5755 USD) is 99% less than its Relative Value (44.9605 USD). Open Relative Valuation
AUVI.
AUVI has positive Gross Profit for the last twelve months.
AUVI's long-term assets (58m USD) exceed its long-term liabilties (34m USD).
AUVI's Revenue has grown by an exceptional 102% over the past 12 months.
AUVI's ROE (Return on Equity) has significantly decreased in the last 3 years from -47% to -70%, and is approaching profitability.
AUVI's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -65% to -35%, and is approaching profitability.
AUVI has negative Operating Income for the last twelve months.
AUVI has negative Net Income for the last twelve months.
AUVI's ROE (Return on Equity) for the past 12 months is negative and is equal to -70%.
AUVI's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -35%.
AUVI's short-term liabilties (28m USD) exceed its short-term assets (17m USD).
AUVI has positive Net Debt. This means that the company has more debt (4m USD) than cash and short-term investments (1m USD).
AUVI has negative Free Cash Flow for the last twelve months.
AUVI's Revenue has been growing by an exceptional 92% per year for the last 3 years.
AUVI's D/E (Debt to Equity) is very low and is equal to 0.18.
AUVI has negative three-year average ROE (Return on Equity): -58%. The company is not efficient at transforming stockholders' equity into net income.
AUVI has very high three-year average ROIC (Return on Invested Capital): 607%. The company is very efficient at using invested capital to generate operating income.
AUVI's Altman Z-Score is very low and is equal to -1.26.
AUVI doesn't generate enough operating income (-13m USD) to safely cover interest payments on its debt (816k USD).
Fundamental Analysis
Applied UV Inc
Balance Sheet Decomposition
Applied UV Inc
| Current Assets | 17m |
| Cash & Short-Term Investments | 1.1m |
| Receivables | 3.9m |
| Other Current Assets | 12m |
| Non-Current Assets | 41.4m |
| PP&E | 4.4m |
| Intangibles | 36.9m |
| Other Non-Current Assets | 61.5k |
| Current Liabilities | 27.9m |
| Accounts Payable | 9.2m |
| Accrued Liabilities | 1.7m |
| Short-Term Debt | 200k |
| Other Current Liabilities | 16.8m |
| Non-Current Liabilities | 5.6m |
| Long-Term Debt | 4.2m |
| Other Non-Current Liabilities | 1.4m |
Earnings Waterfall
Applied UV Inc
|
Revenue
|
40.7m
USD
|
|
Cost of Revenue
|
-32.9m
USD
|
|
Gross Profit
|
7.8m
USD
|
|
Operating Expenses
|
-20.9m
USD
|
|
Operating Income
|
-13.1m
USD
|
|
Other Expenses
|
-1.7m
USD
|
|
Net Income
|
-14.8m
USD
|
Free Cash Flow Analysis
Applied UV Inc
AUVI Profitability Score
Profitability Due Diligence
Applied UV Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Applied UV Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
AUVI Solvency Score
Solvency Due Diligence
Applied UV Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Score
Applied UV Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AUVI Price Targets Summary
Applied UV Inc
Ownership
AUVI Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
AUVI Price
Applied UV Inc
| Average Annual Return | -52.25% |
| Standard Deviation of Annual Returns | 23.2% |
| Max Drawdown | -100% |
| Market Capitalization | 719.4k USD |
| Shares Outstanding | 1 250 000 |
| Percentage of Shares Shorted | 3.7% |
Company Profile
Applied UV Inc
Country
Industry
Market Cap
Dividend Yield
Description
Applied UV, Inc. engages in the development and acquisition of technology that address infection prevention in the healthcare, hospitality, commercial and residential markets. The company is headquartered in Mount Vernon, New York and currently employs 61 full-time employees. The company went IPO on 2020-08-27. The firm's disinfectant segment is engaged in the design, manufacture, assembly and distribution of disinfecting systems for use in healthcare, hospitality, and commercial municipal and residential markets. Its hospitality segment is engaged in the manufacture of mirrors specifically for the hospitality industry. Its subsidiary, SteriLumen, Inc. (SteriLumen), develops and acquires medical devices that eliminate pathogens that may cause healthcare-acquiured infections (HAIs) for distribution primarily to facilities that have customer turnover, such as hospitals, assisted living facilities, doctors’ offices and walk-in clinics as well as other public spaces. The company manufactures and supplies decorative framed mirrors, framed art, and vanities primarily to the hospitality market through Munn Works, LLC (Munn Works).
You don't have any saved screeners yet
